drug

Mifepristone (RU-486)

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Stanford University
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
Treatment of Psychotic Major Depression With Mifepristone
NCT00867360Phase 3Terminated

KOLs & investigators

1
Fredric B Kraemer

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Stanford University
company
trial
Treatment of Psychotic Major Depression With Mifepristone
PHASE3
trial
indication
Affective Disorders, Psychotic
indication
Affective Disorders, Psychotic
indication
Depressive Disorder
indication
Depressive Disorder
indication
KOL
Fredric B Kraemer
KOL score —
person